Trial intelligence / Profile preview

Thiomersal-Free Influsplit SSW® 2002/2003 vs Standard Formulation

NCT00731029Phase 3Completed

Sponsor
GSK
Start
Sep 2002
Primary completion
Apr 2003
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Fluarix in influenza, sponsored by GSK. Started Sep 2002; status: completed.

02

Drugs

Fluarix
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00731029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00731029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call